1. BioMedical Cluster New opportunities for innovators and investors with Bio-Medical Cluster of Skolkovo Foundation Innovation in Medical Technologies Conference, Moscow, 2012

3. WHAT WE PROVIDE? 3 “Care, education and growth”: Access to R&D infrastructure Partnering Investment Business trainings and consulting PR GR “Treatment and nutrition”: Tax benefits IP protection Mini-Grants Grants up to $10M per project “Diagnosis”: Scientific and technical evaluation of ideas ( DD)

4. Key differentiators/ benefits for setting up innovative facilities with/ in Skolkovo Local partners for shared risk, expertise in local practice and markets, access to key decision making bodies, and endorsement. Investor friendly environment, a setup that facilitates access to, and opportunities for, investment, and facilitated access to a government investment agency (Russian Venture Company). BioMedical Cluster

5. “One-Stop-Shop” 5 Provide residents with all essential services Let them focus on their business

6. Special conditions for startups in Skolkovo No VAT or profit tax for 10 years 6 Refund of customs duties and VAT on imported equipment 14% unified social tax rate (vs. normal 34%) OECD tech regulations apply

7. What BMT Skolkovo is, what BMT Skolkovo isn’t 7 We provide financial grants We are non-profit We finance and support R&D and early-stage companies We are a platform for international collaboration in R&D and technology transfer We support and finance both Russian and international innovation We are not an investment fund; we do not invest, take equity stakes or board seats We don’t finance production or advanced commercial activity We are not a sales agent We are not limited to Russian technology; our mandate is to enhance 2-way tech transfer

8. BioMedical Cluster What & Why? Respond to: –Lack of biomed industry in Russia –Russian excellence in physical and mathematical sciences, and engineering –Political support for local development of innovative medications –Needs for improvement in health care

9. BioMedical Cluster MAIN FORESIGHTS: Research Systems Biology/ Medicine Bioinformatics Translational Medicine Functional and Structural Genomics Cell and tissue engineering Biomaterials Biosensors Drug discovery based on the above Device and medical equipment construction

10. 10 BioMedical Cluster Number of approved applications: 148 Grant Committee approved funding $ 87 M14 partcipants Between December 2010 and January 2012$ 30 M The total volume of investments in projects from external sources $ 55 M Issued to two companies $ 100 K. Participant Companies Grants First tranche Foreign Investment Mini-grants

11. BioMedical Cluster Collaborations, national and international cooperations

12. We welcome partners for: joint development of technology and science that creates commercial opportunities and builds capacity and capability in Russia. BioMedical Cluster

13. Thank you!